<DOC>
	<DOCNO>NCT00540800</DOCNO>
	<brief_summary>Some chemotherapy , include docetaxel , well tolerate effective give dose weekly rather every three week basis . The purpose study compare 2 schedule combination chemotherapy docetaxel effect quality life . Standard every three week chemotherapy compare weekly chemotherapy metastatic locally advanced breast cancer .</brief_summary>
	<brief_title>BREAST-10 : Three-weekly Versus Weekly First-line Chemotherapy Metastatic Locally Advanced Breast Cancer</brief_title>
	<detailed_description>Patients locally advance breast cancer patient metastatic breast cancer previously receive anthracycline treat docetaxel epirubicin . Patients metastatic breast cancer already receive anthracyclines treat docetaxel capecitabine . All patient randomize receive treatment either every three week schedule , weekly schedule .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>Histological diagnosis breast cancer Inoperable locally advance metastatic disease yet treat firstline chemotherapy Age &lt; 70 year ECOG performance status &lt; 2 Written inform consent Previous concomitant malignant neoplasm ( exclude adequately treat baso spinocellular skin carcinoma carcinoma situ cervix ) Previous treatment docetaxel Symptomatic brain metastasis Neutrophil &lt; 2000/mm3 , platelet &lt; 100,000/mm3 , haemoglobin &lt; 10 g/dl Creatinine &gt; 1.25 x upper normal limit GOT and/or GPT &gt; 1.25 x upper normal limit absence hepatic metastasis GOT and/or GPT &gt; 2.5 x upper normal limit presence hepatic metastasis Bilirubin &gt; 1.5 x upper normal limit Any concomitant pathology would , investigator 's opinion , contraindicate use drug study Inability provide inform consent Inability comply followup</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>anthracycline pre-treated</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>first-line</keyword>
	<keyword>metastatic breast cancer</keyword>
	<keyword>locally advanced breast cancer</keyword>
</DOC>